Sites of positive allosteric modulation by neurosteroids on ionotropic γ-aminobutyric acid receptor subunits

FEBS Letters

Volumn 566, Issue 1-3, 2004, Pages 213-217

  Ueno, Susumu ^a   Tsutsui, Masato ^a   Toyohira, Yumiko ^a   Minami, Kouichiro ^a   Yanagihara, Nobuyuki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chimera; GABAA receptor; GABAC receptor; Glycine receptor; Neurosteroid; Xenopus oocyte

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; NEUROSTEROID; RECEPTOR SUBUNIT; TETRAHYDRODEOXYCORTICOSTERONE;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; XENOPUS;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; DESOXYCORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; FEMALE; HUMANS; MOLECULAR SEQUENCE DATA; OOCYTES; PREGNANOLONE; PROTEIN SUBUNITS; RECEPTORS, GABA-A; RECOMBINANT PROTEINS; XENOPUS LAEVIS; XENOPUS PROTEINS;

EID: 2442506898     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2004.04.030     Document Type: Article

References (29)

1. Ortells M.O., Lunt G.G. Trends Neurosci. 18:1995;121-127
2. Olsen R.W. Toxicol. Lett. 100-101:1998;193-201
3. Paul S.M., Purdy R.H. FASEB J. 6:1992;2311-2322
4. Rupprecht R., Holsboer F. Trends Neurosci. 22:1999;410-416
5. Hill-Venning C., Belelli D., Peters J.A., Lambert J.J. Br. J. Pharmacol. 120:1997;749-756
6. Belelli D., Casula A., Ling A., Lambert J.J. Neuropharmacology. 4:2002;651-661
7. Zhang D., Pan Z.H., Awobuluyi M., Lipton S.A. Trends Pharmacol. Sci. 22:2001;121-132
8. Kokate T.G., Cohen A.L., Karp E., Rogawski M.A. Neuropharmacology. 35:1996;1049-1056
9. Crawley J.N., Glowa J.R., Majewska M.D., Paul S.M. Brain Res. 398:1986;382-385
10. Wieland S., Lan N.C., Mirasedeghi S., Gee K.W. Brain Res. 565:1991;263-268
11. Rodgers R.J., Johnson N.J. Pharmacol. Biochem. Behav. 59:1998;221-232
12. Mendelson W.B., Martin J.V., Perlis M., Wagner R., Majewska M.D., Paul S.M. Psychopharmacology (Berlin). 93:1987;226-229
13. Müller-Preuss P., Rupprecht R., Lancel M. Neuroreport. 13:2002;487-490
14. Morris K.D., Moorefield C.N., Amin J. Mol. Pharmacol. 56:1999;752-759
15. Rick C.E., Ye Q., Finn S.E., Harrison N.L. Neuroreport. 9:1998;379-383
16. Pistis M., Belelli D., Peters J.A., Lambert J.J. Br. J. Pharmacol. 122:1997;1707-1719
17. Belelli D., Pistis M., Peters J.A., Lambert J.J. Neurochem. Int. 34:1999;447-452
18. Sanna E., Garau F., Harris R.A. Mol. Pharmacol. 47:1995;213-217
19. Mihic S.J., Ye Q., Wick M.J., Koltchine V.V., Krasowski M.D., Finn S.E., Mascia M.P., Valenzuela C.F., Hanson K.K., Greenblatt E.P., Harris R.A., Harrison N.L. Nature. 389:1997;385-389
20. Wick M.J., Mihic S.J., Ueno S., Mascia M.P., Trudell J.R., Brozowski S.J., Ye Q., Harrison N.L., Harris R.A. Proc. Natl. Acad. Sci. USA. 95:1998;6504-6509
21. Ueno S., Lin A., Nikolaeva N., Trudell J.R., Mihic S.J., Harris R.A., Harrison N.L. Br. J. Pharmacol. 131:2000;296-302
22. Beckstead M.J., Weiner J.L., Eger 2nd E.I., Gong D.H., Mihic S.J. Mol. Pharmacol. 57:2000;1199-1205
23. Carlson B.X., Engblom A.C., Kristiansen U., Schousboe A., Olsen R.W. Mol. Pharmacol. 57:2000;474-484
24. Maitra R., Reynolds J.N. Brain Res. 819:1999;75-82
25. Lee Y.H., Li L., Lasalde J., Rojas L., McNamee M., Ortiz-Miranda S.I., Pappone P. Biophys. J. 66:1994;646-653
26. Tamamizu S., Lee Y., Hung B., McNamee M.G., Lasalde-Dominicci J.A. J. Membr. Biol. 170:1999;157-164
27. Jenkins A., Andreasen A., Trudell J.R., Harrison N.L. Neuropharmacology. 43:2002;669-678
28. Paradiso K., Zhang J., Steinbach J.H. J. Neurosci. 21:2001;6561-6568
29. Curtis L., Buisson B., Bertrand S., Bertrand D. Mol. Pharmacol. 61:2002;127-135